Table 1 Patient characteristics at baseline
Number of patients | N | Mean | Min | Max |
|---|---|---|---|---|
Age (years) | 79 | 49.3 | 23.0 | 72.6 |
Gender (female) | 79 | 50.6 % | ||
Duration since diagnosis (years) | 79 | 8.0 | 0.0 | 27.5 |
Enzyme activity (% of normal) | 79 | 12.4 | 0.5 | 19.9 |
Muscle strength (% predicted) | 64 | 82.1 | 48.3 | 100.0 |
Respiratory function (% predicted) | 63 | 76.1 | 11.3 | 123.4 |
Fatigue Severity Scale | 61 | 5.6 | 2 | 7 |
Rotterdam Handicap Scale | 64 | 27.4 | 13.5 | 36.0 |
Visual Analogue Scale | 49 | 65.0 | 30.0 | 95.0 |
Mental Component Scale | 60 | 53.8 | 24.2 | 74.0 |
Physical Component Scale | 60 | 35.4 | 17.6 | 53.3 |
EQ-5D Utility | 50 | 0.736 | 0.201 | 1.000 |